Anaplastic ependymoma in pediatric population
Ependymomas in the pediatric population should be considered high risk if the patient is younger than 3 years of age at the time of diagnosis, if he has preoperative metastases, features of anaplasia, or residual tumor, surgery as a therapeutic modality is the one that Provides greater disease-free survival, adjuvant therapy does not determine predictive value.











